BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37558303)

  • 1. Short-Coupled Ventricular Fibrillation.
    Steinberg C
    Card Electrophysiol Clin; 2023 Sep; 15(3):331-341. PubMed ID: 37558303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry.
    Steinberg C; Davies B; Mellor G; Tadros R; Laksman ZW; Roberts JD; Green M; Alqarawi W; Angaran P; Healey J; Sanatani S; Leather R; Seifer C; Fournier A; Duff H; Gardner M; McIntyre C; Hamilton R; Simpson CS; Krahn AD
    Eur Heart J; 2021 Jul; 42(29):2827-2838. PubMed ID: 34010395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Coupled Idiopathic Ventricular Fibrillation: A Literature Review With Extended Follow-Up.
    Belhassen B; Tovia-Brodie O
    JACC Clin Electrophysiol; 2022 Jul; 8(7):918-936. PubMed ID: 35597766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes.
    Tsai CF; Chen SA; Tai CT; Chiang CE; Ding YA; Chang MS
    Int J Cardiol; 1998 Mar; 64(1):47-55. PubMed ID: 9579816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization.
    Aizawa Y; Chinushi M; Hasegawa K; Naiki N; Horie M; Kaneko Y; Kurabayashi M; Ito S; Imaizumi T; Aizawa Y; Takatsuki S; Joo K; Sato M; Ebe K; Hosaka Y; Haissaguerre M; Fukuda K
    J Am Coll Cardiol; 2013 Sep; 62(11):1015-9. PubMed ID: 23747791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic ventricular fibrillation - Long term prognosis in relation to clinical findings and ECG patterns in a Swedish cohort.
    Chaudhry U; Platonov PG; Rubulis A; Bergfeldt L; Jensen SM; Lundin C; Borgquist R
    J Electrocardiol; 2019; 56():46-51. PubMed ID: 31280131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy.
    Kakishita M; Kurita T; Matsuo K; Taguchi A; Suyama K; Shimizu W; Aihara N; Kamakura S; Yamamoto F; Kobayashi J; Kosakai Y; Ohe T
    J Am Coll Cardiol; 2000 Nov; 36(5):1646-53. PubMed ID: 11079671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phenotypic combination of idiopathic VF and Brugada syndrome.
    Martinek M; Purerfellner H
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):e84-7. PubMed ID: 20230473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: results from a multicentre long-term registry.
    Conte G; Belhassen B; Lambiase P; Ciconte G; de Asmundis C; Arbelo E; Schaer B; Frontera A; Burri H; Calo' L; Letsas KP; Leyva F; Porter B; Saenen J; Zacà V; Berne P; Ammann P; Zardini M; Luani B; Rordorf R; Sarquella Brugada G; Medeiros-Domingo A; Geller JC; de Potter T; Stokke MK; Márquez MF; Michowitz Y; Honarbakhsh S; Conti M; Sticherling C; Martino A; Zegard A; Özkartal T; Caputo ML; Regoli F; Braun-Dullaeus RC; Notarangelo F; Moccetti T; Casu G; Rinaldi CA; Levinstein M; Haugaa KH; Derval N; Klersy C; Curti M; Pappone C; Heidbuchel H; Brugada J; Haïssaguerre M; Brugada P; Auricchio A
    Europace; 2019 Nov; 21(11):1670-1677. PubMed ID: 31504477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early repolarization pattern and its day-to-day dynamic change as markers for ventricular fibrillation in patients with vasospastic angina.
    Kitamura T; Fukamizu S; Hojo R; Aoyama Y; Komiyama K; Nishizaki M; Sakurada H; Hiraoka M
    Europace; 2016 Aug; 18(8):1252-8. PubMed ID: 26559917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators.
    Anthony R; Daubert JP; Zareba W; Andrews ML; McNitt S; Levine E; Huang DT; Hall WJ; Moss AJ;
    Pacing Clin Electrophysiol; 2008 Feb; 31(2):144-50. PubMed ID: 18233965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of spontaneous initiation of ventricular fibrillation in patients with implantable defibrillators.
    Xie E; Mayer K; Capps MF; Barth AS; Love CJ; Coronel R; Ashikaga H
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2415-2424. PubMed ID: 32618399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed characterization of familial idiopathic ventricular fibrillation linked to the DPP6 locus.
    Ten Sande JN; Postema PG; Boekholdt SM; Tan HL; van der Heijden JF; de Groot NM; Volders PG; Zeppenfeld K; Boersma LV; Nannenberg EA; Christiaans I; Wilde AA
    Heart Rhythm; 2016 Apr; 13(4):905-12. PubMed ID: 26681609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Follow-Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications.
    Frontera A; Vlachos K; Kitamura T; Mahida S; Pillois X; Fahy G; Marquie C; Cappato R; Stuart G; Defaye P; Kaski JP; Ector J; Maltret A; Scanu P; Pasquie JL; Deisenhofer I; Blankoff I; Scherr D; Manninger M; Aizawa Y; Koutbi L; Denis A; Pambrun T; Ritter P; Sacher F; Hocini M; Maury P; Jaïs P; Bordachar P; Haïssaguerre M; Derval N
    J Am Heart Assoc; 2019 May; 8(9):e011172. PubMed ID: 31057083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients.
    Blom LJ; Visser M; Christiaans I; Scholten MF; Bootsma M; van den Berg MP; Yap SC; van der Heijden JF; Doevendans PA; Loh P; Postema PG; Barge-Schaapsveld DQ; Hofman N; Volders PGA; Wilde AA; Hassink RJ
    Europace; 2019 Oct; 21(10):1519-1526. PubMed ID: 31114860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
    Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of J wave-associated idiopathic ventricular fibrillation: role of drugs.
    Chinushi M; Hasegawa K; Iijima K; Furushima H; Izumi D; Sato A; Aizawa Y
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):e226-30. PubMed ID: 21418245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
    De Maria E; Cappelli S; Cappato R
    Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298
    [No Abstract]   [Full Text] [Related]  

  • 20. Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias.
    Crijns HJ; Wiesfeld AC; Posma JL; Lie KI
    Br Heart J; 1995 Oct; 74(4):408-12. PubMed ID: 7488456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.